Next Generation Digital Natural History Study for CHD2

Ciitizen / Invitae

Next Generation Digital Natural History Study

What is a Natural History Study and Why Do they Matter?

Natural History Studies (NHS) are critical to the drug development process. Ciitizen has developed a new method to make this process easier. A next generation, digital NHS for CHD2-related disorders is expected to facilitate:

Informing clinical researchers how a disease changes over time
Enabling better endpoint selection to use in clinical trials
Understanding the connection between mutation types and symptoms
Reducing the time it takes to study new medicines in clinical trials
Speeding up the time to get therapeutics to patients
Using data as a placebo (instead of actual patients) in a clinical trial

How it Works

Participation is completely digital - No clinic visits required
Collects participant's medical records from the institutions visited
Data from medical records is organized and summarized, free of charge to the participant
Participants retain full control of their health records
With your consent, clinicians, researchers and biopharma can access anonymized data to aid in research
Available now in the US with plans for worldwide availability
Registering with Ciitizen requires less than 10 minutes of your time

Have you or your loved one been diagnosed with CHD2?

More Info:

Ongoing Studies

RARE-X Study

Participating in a data collection program is one of the most important things that families with a child with CHD2-related neurodevelopmental disorders can do.